Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6T2R

Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown

This is a non-PDB format compatible entry.
Summary for 6T2R
Entry DOI10.2210/pdb6t2r/pdb
DescriptorBeta-glycosidase, SULFATE ION (3 entities in total)
Functional Keywordshuman gut microbiota, mucin degradation, o-glycanases, gh16, endo beta-galactosidase, hydrolase
Biological sourceBacteroides caccae
Total number of polymer chains1
Total formula weight30681.00
Authors
Primary citationCrouch, L.I.,Liberato, M.V.,Urbanowicz, P.A.,Basle, A.,Lamb, C.A.,Stewart, C.J.,Cooke, K.,Doona, M.,Needham, S.,Brady, R.R.,Berrington, J.E.,Madunic, K.,Wuhrer, M.,Chater, P.,Pearson, J.P.,Glowacki, R.,Martens, E.C.,Zhang, F.,Linhardt, R.J.,Spencer, D.I.R.,Bolam, D.N.
Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown.
Nat Commun, 11:4017-4017, 2020
Cited by
PubMed Abstract: The thick mucus layer of the gut provides a barrier to infiltration of the underlying epithelia by both the normal microbiota and enteric pathogens. Some members of the microbiota utilise mucin glycoproteins as a nutrient source, but a detailed understanding of the mechanisms used to breakdown these complex macromolecules is lacking. Here we describe the discovery and characterisation of endo-acting enzymes from prominent mucin-degrading bacteria that target the polyLacNAc structures within oligosaccharide side chains of both animal and human mucins. These O-glycanases are part of the large and diverse glycoside hydrolase 16 (GH16) family and are often lipoproteins, indicating that they are surface located and thus likely involved in the initial step in mucin breakdown. These data provide a significant advance in our knowledge of the mechanism of mucin breakdown by the normal microbiota. Furthermore, we also demonstrate the potential use of these enzymes as tools to explore changes in O-glycan structure in a number of intestinal disease states.
PubMed: 32782292
DOI: 10.1038/s41467-020-17847-5
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

231356

數據於2025-02-12公開中

PDB statisticsPDBj update infoContact PDBjnumon